US And Canada

U-M commits $20m to four spinouts
University of Michigan will supply an initial $2.75m in funding to MemryX, Ripple Science, GreenMark Biomedical, and Give and Take, and could invest as much as $20m altogether.
Neuspera restimulates $26m series B
Neuspera Medical has secured a $12m extension to bring its series B round to the targeted $26m close, with all investors from the first tranche returning.
TTU’s Innovation Hub spawns 12 businesses
TTU Innovation Hub graduated six companies from its accelerator and helped its wider affiliate community secure a total of $3.5m in grant funding.
Phylagen traces corporates for $14m series A
The environmental microbiome testing kit maker, based on Oregon research, has collected series A capital from investors including Western Digital Capital and 3M Ventures.
Laurentian hires Haché
Robert Haché will end his tenure as vice-president of research and innovation at York University to lead Laurentian University from July.
Jandhyala bids CoMotion farewell
Vikram Jandhyala is standing down as executive director of University of Washington’s CoMotion but will remain with the university in other capacities.
Glycotest captures $3m from Fosun Pharma
The liver disease diagnostics spinout has secured the first tranche of a $10m series A investment by Fosun Pharma initially announced in October 2018.
Maryland mulls $16m Tedco program
State lawmakers are considering plans to fund supports for Maryland’s cybersecurity and life sciences sectors administered by local economic development agency Tedco.

Other News

Passage Bio follows $116m series A trajectory
Passage Bio will develop therapies for diseases affecting the central nervous system based on research by James Wilson at Penn, after raising almost $116m in a series A round.
Vor roars to $42m series A
Osage University Partners has contributed to a series A round for Vor Biopharma, an oncology drug developer based on work by Siddhartha Mukherjee at Columbia University.
Sitka sets up $1.2m
UBC and CDRD spinout Sitka Biopharma has now lured $5.5m in total and is readying its bladder cancer treatment for initial clinical trials.
Complion complies for $7m series B
Complion collected funding from investors including the multi-university-backed Ohio Innovation Fund for its regulatory compliance software platform catered to sites conducting clinical research.
Chylla becomes Autm chairman
Richard Chylla, executive director of MSU Technologies, has taken over as chairman of Autm's board of directors, succeeding Alison Campbell.
Minnesota fuels incubator
University of Minnesota's Discovery Launchpad incubator is currently supporting eight projects based on university research with resources including office space and mentoring.

Editor's Picks

Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Editorial: For the good of investors
As MedWhat scores an initial win in its courtroom battle with Stanford, Paige.ai finds itself in the middle of allegations that its licensing deal with Sloan Kettering was improper.
Big deal: Ambys arrives at $140m investment
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Big deal: QuantumScape fuels up on VW cash
VW will invest $100m in QuantumScape and form a joint venture with the Stanford spinout to develop batteries for long-range electric vehicles.
test reg

Login